RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ASKA Pharmaceutical Holdings Co Stock

ASKA Pharmaceutical Holdings Co Liabilities 2024

ASKA Pharmaceutical Holdings Co Liabilities

28.82 B JPY

Ticker

4886.T

ISIN

JP3119660003

In 2024, ASKA Pharmaceutical Holdings Co's total liabilities amounted to 28.82 B JPY, a -16.25% difference from the 34.41 B JPY total liabilities in the previous year.

ASKA Pharmaceutical Holdings Co Aktienanalyse

What does ASKA Pharmaceutical Holdings Co do?

ASKA Pharmaceutical Holdings Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing ASKA Pharmaceutical Holdings Co's Liabilities

ASKA Pharmaceutical Holdings Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating ASKA Pharmaceutical Holdings Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing ASKA Pharmaceutical Holdings Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

ASKA Pharmaceutical Holdings Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in ASKA Pharmaceutical Holdings Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about ASKA Pharmaceutical Holdings Co stock

What is the level of liabilities of ASKA Pharmaceutical Holdings Co this year?

ASKA Pharmaceutical Holdings Co has a debt balance of 28.82 B JPY this year.

What were the liabilities of ASKA Pharmaceutical Holdings Co compared to the previous year?

The liabilities of ASKA Pharmaceutical Holdings Co have increased by -16.25% dropped compared to the previous year.

What are the consequences of high debt for investors of ASKA Pharmaceutical Holdings Co?

High liabilities can pose a risk for investors of ASKA Pharmaceutical Holdings Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in ASKA Pharmaceutical Holdings Co?

Low liabilities mean that ASKA Pharmaceutical Holdings Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of ASKA Pharmaceutical Holdings Co affect the company?

An increase in liabilities of ASKA Pharmaceutical Holdings Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of ASKA Pharmaceutical Holdings Co affect the company?

A decrease in the liabilities of ASKA Pharmaceutical Holdings Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of ASKA Pharmaceutical Holdings Co?

Some factors that can influence the liabilities of ASKA Pharmaceutical Holdings Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of ASKA Pharmaceutical Holdings Co so important for investors?

The liabilities of ASKA Pharmaceutical Holdings Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can ASKA Pharmaceutical Holdings Co take to modify the liabilities?

To change its liabilities, ASKA Pharmaceutical Holdings Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does ASKA Pharmaceutical Holdings Co pay?

Over the past 12 months, ASKA Pharmaceutical Holdings Co paid a dividend of 45 JPY . This corresponds to a dividend yield of about 2.11 %. For the coming 12 months, ASKA Pharmaceutical Holdings Co is expected to pay a dividend of 48.3 JPY.

What is the dividend yield of ASKA Pharmaceutical Holdings Co?

The current dividend yield of ASKA Pharmaceutical Holdings Co is 2.11 %.

When does ASKA Pharmaceutical Holdings Co pay dividends?

ASKA Pharmaceutical Holdings Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of ASKA Pharmaceutical Holdings Co?

ASKA Pharmaceutical Holdings Co paid dividends every year for the past 12 years.

What is the dividend of ASKA Pharmaceutical Holdings Co?

For the upcoming 12 months, dividends amounting to 48.3 JPY are expected. This corresponds to a dividend yield of 2.27 %.

In which sector is ASKA Pharmaceutical Holdings Co located?

ASKA Pharmaceutical Holdings Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von ASKA Pharmaceutical Holdings Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ASKA Pharmaceutical Holdings Co from 12/1/2024 amounting to 25 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did ASKA Pharmaceutical Holdings Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of ASKA Pharmaceutical Holdings Co in the year 2023?

In the year 2023, ASKA Pharmaceutical Holdings Co distributed 28 JPY as dividends.

In which currency does ASKA Pharmaceutical Holdings Co pay out the dividend?

The dividends of ASKA Pharmaceutical Holdings Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ASKA Pharmaceutical Holdings Co

Our stock analysis for ASKA Pharmaceutical Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ASKA Pharmaceutical Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.